BBI Solutions will showcase its pioneering lateral flow diagnostics technology as sponsor of the Next Generation Dx Summit in Washington later this month.
BBI Solutions will showcase its pioneering lateral flow diagnostics technology as sponsor of the Next Generation Dx Summit in Washington later this month.
The 10th annual Next Generation Dx Summit, 20 – 24th August, is expected to attract more than 1,000 industry professionals from across the global diagnostics sector. The conference invites leading industry figures to discover and share in the latest technological advancements for diagnostic testing.
As a sponsor of the summit, BBI Solutions will deliver a presentation on improving the performance and connectivity of lateral flow assays for diagnostic applications during the five-day conference.
Product Manager, Lateral Flow Services and Detection, David Fraser will present BBI Solutions’ unique Morffi™ signal enhancement technology, which has the potential to provide companies with a key competitive advantage because of the improved performance and faster results it offers.
Morffi’ technology provides an up to ten-fold improvement in the limit of detection, enhanced assay sensitivity and may offer a faster time-to-result for situations where a quick diagnosis is crucial to patient care.
David Fraser commented: “We’re excited to be joining some of the biggest names in the diagnostic sector at Next Generation Dx and having the opportunity to promote BBI Solutions’ unique service offering for a second consecutive year at the summit. BBI’s innovative lateral flow solution empowers customers to achieve their assay goals through just one company, creating a simplified and streamlined service.”
As part of the presentation, BBI Group Head of Mobile and NovarumTM DX Founder, Dr Neil Polwart, will also discuss how the smartphone is revolutionising point of care diagnostics as traditional healthcare shifts towards more decentralised patient care.
Dr Polwart commented: “Disruptive technology is having a major impact on the healthcare sector and we’re delighted to be part of a summit that supports innovative technologies with real potential to transform the future of point of care testing.”
Acquired by BBI Solutions in 2016, Novarum has revolutionised diagnostic testing by transforming a smartphone into a test reader. Results of disposable tests for toxicology, infectious or auto-immune disease are accurately read and shared securely with healthcare professionals online.
For more information about the BBI Solutions’ and Novarum presentation, visit: https://www.bbisolutions.com/en/about-us/events.html
ENDS
Media Enquiries:
This release was issued by Influential on behalf of BBI Solutions. For more information, please contact Ruth Cobban or Steph Bocking on 0151 239 5000 or email: cobban@thisisinfluential.com bocking@thisisinfluential.com
About BBI Solutions
BBI Solutions is a leading manufacturer of biological reagents and finished test platforms for the in-vitro diagnostics market. BBI is a global business with manufacturing sites spanning three continents.
Our range of raw materials includes human antigens, antibodies, serum and plasma products and clinical chemistry enzymes. We manufacture world renowned labels for lateral flow, ELISA assay and biosensors, including our gold nanoparticles and glucose oxidase.
BBI Solutions offers lateral flow development and manufacturing services with a core focus on gold conjugation and lateral flow test manufacture.
BBI Solutions is part of the BBI Group.
